Tepmetko

tepotinib

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Tepmetko, covering 2021-02-03 to 2026-04-17. Get the full timeline:

Most recent: EMA Authorised: Tepmetko (tepotinib hydrochloride monohydrate) — Merck Europe B.V.